Retention of Suboxone Patients in START: Perspectives of Providers and Patients Yih-Ing Hser, Ph.D. Lead Investigator Integrated Substance Abuse Programs University of California, Los Angeles 1640 South Sepulveda Blvd., Suite 200 Los Angeles, CA 90025 ysher@ucla.edu

This ancillary study is related to CTN-0027, "Starting Treatment with Agonist Replacement Therapies (START)."

The overall purposes of this supplemental study are (1) to identify barriers for retaining Suboxone patients in START, and (2) to address the barriers if study conditions and findings permit.

LATEST PUBLICATIONS AND DATA

	Find publications in the Library about Protocol CTN-0027-A-2